Non-alcoholic Steatohepatitis Drugs Pipeline Market

Non-alcoholic Steatohepatitis Drugs Pipeline Market

Non-alcoholic Steatohepatitis Drugs Pipeline Market: Global Industry Analysis 2019-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Non-alcoholic Steatohepatitis Drugs Pipeline offers a global industry analysis for 2019-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Phases:

• Pre-clinical and Discovery stage candidates
• Early-stage product (Phase I)
• Mid-stage products (Phase II)
• Late-stage products (Phase III)

By Drugs:

• Saroglitazar Magnesium
• VK-1430
• GMA-107
• Resmetirom (MGL-3196)
• MSDC-0602K
• ION-224
• HTD 1801
• JKB-121
• EDP-305
• TERN-101
• EYP001
• SNP-610
• SNP-630
• Lanifibranor
• Firsocostat
• Tirzepatide
• Others

By Molecules:

• Small Molecules
• Biologics
• Oligonucleotides

By Route of Administration:

• Oral
• Subcutaneous
• Others

By Mechanism of Action:

• Receptor Agonist
• Enzyme Inhibitor
• Protein & Peptide Inhibitor
• Receptor Antagonist
• Others

By Region:

• North America
• Europe
• Latin America
• East Asia
• South Asia & Pacific

Report Chapters

Executive Summary

The executive summary of the Non-alcoholic Steatohepatitis Drugs Pipeline Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Non-alcoholic Steatohepatitis Drugs Pipeline Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Non-alcoholic Steatohepatitis Drugs Pipeline Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Phases processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Non-alcoholic Steatohepatitis Drugs Pipeline Market Demand Analysis 2019-2022 and Forecast, 2023-2033

The chapter include historical market value (USD 0.26 Billion) analysis (2019-2022) and current and future market value (USD 0.27 Billion) and volume (33.3%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Non-alcoholic Steatohepatitis Drugs Pipeline Market - Pricing Analysis

Based on By Phases, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033, By Phases

Based on By Phases, Non-alcoholic Steatohepatitis Drugs Pipeline Market is segmented into Pre-clinical and Discovery stage candidates, Early-stage product (Phase I), Mid-stage products (Phase II), Late-stage products (Phase III). Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Phases.

Chapter 06 - Global Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033, By Drugs

Based on By Drugs, Non-alcoholic Steatohepatitis Drugs Pipeline Market is segmented into Saroglitazar Magnesium, VK-1430, GMA-107, Resmetirom (MGL-3196), MSDC-0602K, ION-224, HTD 1801, JKB-121, EDP-305, TERN-101, EYP001, SNP-610, SNP-630, Lanifibranor, Firsocostat, Tirzepatide, Others. This section also offers market attractiveness analysis based on By Drugs. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drugs.

Chapter 07 - Global Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033, By Molecules

Based on By Molecules, Non-alcoholic Steatohepatitis Drugs Pipeline Market is segmented into Small Molecules, Biologics, Oligonucleotides. This section also offers market attractiveness analysis based on By Molecules. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Molecules.

Chapter 08 - Global Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033, By Route of Administration

Based on By Route of Administration, Non-alcoholic Steatohepatitis Drugs Pipeline Market is segmented into Oral, Subcutaneous, Others. This section also offers market attractiveness analysis based on By Route of Administration. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Route of Administration.

Chapter 09 - Global Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033, By Mechanism of Action

Based on By Mechanism of Action, Non-alcoholic Steatohepatitis Drugs Pipeline Market is segmented into Receptor Agonist, Enzyme Inhibitor, Protein & Peptide Inhibitor, Receptor Antagonist, Others. This section also offers market attractiveness analysis based on By Mechanism of Action. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Mechanism of Action.

Chapter 10 - Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033, By Region

Based on By Region, Non-alcoholic Steatohepatitis Drugs Pipeline Market is segmented into North America, Europe, Latin America, East Asia, South Asia & Pacific. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 11 - North America Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 12 - Latin America Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Non-alcoholic Steatohepatitis Drugs Pipeline Market in the Latin America region.

Chapter 13 - Europe Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Non-alcoholic Steatohepatitis Drugs Pipeline Market in the regional market.

Chapter 14 - East Asia Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Non-alcoholic Steatohepatitis Drugs Pipeline Market in the regional market.

Chapter 15 - South Asia Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Non-alcoholic Steatohepatitis Drugs Pipeline Market in the regional market.

Chapter 16 - Middle East and Africa Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Non-alcoholic Steatohepatitis Drugs Pipeline Market in the regional market.

Chapter 17 - Key Countries Non-alcoholic Steatohepatitis Drugs Pipeline Market Analysis 2019-2022 and Forecast 2023-2033

This chapter offers insights into how the Non-alcoholic Steatohepatitis Drugs Pipeline Market is expected to grow in major countries globally.

Chapter 18 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 19 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Phases portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Pfizer Inc., Merck & Co., Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., AstraZeneca, Novartis AG, F. Hoffmann-La Roche Ltd (Genentech, Inc. (Jecure Therapeutics, Inc.)), Novo Nordisk A/S, Gilead Sciences, Viking Therapeutics, ENYO Pharma SA, Enanta Pharmaceuticals, Inc., Oramed, Intercept Pharmaceuticals Inc., Melinta Therapeutics LLC, Boston Pharmaceuticals, CytoDyn Inc., Akero Therapeutics, Inc., SINEW PHARMA INC., AbbVie (Allergan (Tobira Therapeutics Inc.), Eli Lilly & Co., Bristol Myers Squibb Co., Boehringer Ingelheim International , GmbH, NGM Biopharmaceuticals, Sagimet Biosciences, Madrigal Pharmaceuticals, Axcella Therapeutics, TaiwanJ Pharmaceuticals Co., Ltd., Kowa Group (Kowa Company, Ltd.), Hepion Pharmaceuticals, HighTide Therapeutics Inc., Cirius Therapeutics, Gmax Biopharm, TERNS PHARMACEUTICALS, INC., NuSirt Biopharma, Galmed Pharmaceuticals, Ionis Pharmaceuticals, Inc. (Akcea Therapeutics), Inventiva, Histogen, Inc. (Conatuspharma.com).

Chapter 20 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

Chapter 21 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Non-alcoholic Steatohepatitis Drugs Pipeline Market.